vimarsana.com

Latest Breaking News On - Sai life sciences - Page 1 : vimarsana.com

Drug Metabolism And Pharmacokinetics (Dmpk) Market Size, Share Projected to Grow at 8.3% CAGR, Cross

Drug Metabolism And Pharmacokinetics (Dmpk) Market Size, Share Projected to Grow at 8.3% CAGR, Cross
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

United-states
Russia
New-york
Ukraine
America
Pharmacokinetics-dmpk
Asia-pacific
Lawrence-john
Prudour-pvt-ltd
Expansion-of-drug-development-pipeline
Drug-development-activities
Sai-life-sciences

Bharti Hexacom anchors Rs 1,924 cr from investors before IPO opens on April 3

The Bharti Hexacom IPO opens for subscription on April 3, with a price band at Rs 542-570 per share, and closes on April 5.

North-carolina
United-states
Japan
Canara
Karnataka
India
Whiteoak
Blackrock
Abu-dhabi
Abuz-aby
United-arab-emirates
Nippon

SRM Contractors closes at upper circuit, jumps 12.5% on debut

SRM Contractors shares traded in trade-for-trade segment, hence there is a 5 percent upper and lower circuit.

Jammu
Jammu-and-kashmir
India
Sai-life-sciences
Srm-contractors-share-price
Srm-contractors-stock-price
Srm-contractors-nse-price
Srm-contractors-bse-price

Daily Voice: No rate cut before second half of FY25, says Anil Rego

The Right Horizons founder says Indian companies saw more upgrades than downgrades in the previous two quarters despite challenges and the earnings momentum is likely to continue in FY25

India
China
Bharti-hexacom
Blackrock
Sai-life-sciences
Capital-group
Monetary-policy-committee
Anil-rego
Bright-horizons

TPG-backed Sai Life Sciences picks 4 I-banks; to soon kick off Rs 5,000 cr-Rs 5,500 cr IPO

Before switching to the listing route, TPG-backed Sai Life Sciences had explored the sale of a controlling stake in the firm and conducted a sale process, which resulted in Bain Capital emerging as the front-runner in the final leg, according to a January 25 report by Moneycontrol. But talks between both parties did not fructify into a deal

Japan
Hyderabad
Andhra-pradesh
India
United-kingdom
Stelis-biopharma
Cohance-lifesciences
Krishna-kanumuri
Sai-life-sciences-is-syngene
Sai-life-sciences
Aragen-life-sciences
Advent-international

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.